| Literature DB >> 28535762 |
Veronica Cimolin1, Nicola Cau2, Manuela Galli2,3, Cristina Santovito4, Graziano Grugni5, Paolo Capodaglio4.
Abstract
BACKGROUND: Gait Initiation (GI) is a functional task representing one of the first voluntary destabilizing behaviours observed in the development of a locomotor pattern as the whole body centre of mass transitions from a large to a small base of support. Conversely, Gait Termination (GT) consists in the transition from walking to standing which, in everyday life, is a very common movement. Compared to normal walking, it requires higher control of postural stability. For a safe GT, the forward movement of the body has to be slowed down to achieve a stable upright position. Stability requirements have to be fulfilled for safe GT. In individuals with Prader-Willi syndrome (PWS), excessive body weight negatively affects the movement, such as walking and posture, but there are no experimental studies about GI and GT in these individuals. The aim of this study was to quantitatively characterise the strategy of patients with PWS during GI and GT using parameters obtained by the Center of Pressure (CoP) track.Entities:
Keywords: Center of pressure; Gait initiation; Gait termination; Obesity; Prader-Willi syndrome; Rehabilitation
Mesh:
Year: 2017 PMID: 28535762 PMCID: PMC5442593 DOI: 10.1186/s12984-017-0257-7
Source DB: PubMed Journal: J Neuroeng Rehabil ISSN: 1743-0003 Impact factor: 4.262
Fig. 1a Overhead view of Centre of Pressure (COP) displacement in antero-posterior and medio-lateral direction during Gait Initiation (GI). For this task the support sides is the left foot and the swing side is the right foot. b Centre of Pressure (COP) trajectory division for the analysis during GI (APA1, APA2a, APA2b, LOC)
Fig. 2a Overhead view of Centre of Pressure (COP) displacement in antero-posterior and medio-lateral direction during Gait Termination (GT). For this task the support sides is the right foot and the swing side is the left foot (b) Centre of Pressure (COP) trajectory division for the analysis during GT (SPA1, SPA2a, SPA2b, SPA3)
Values of median and quartile range for the calculated parameters during Gait Initiation task
| GAIT INITIATION | |||
|---|---|---|---|
| PWS | OG | HG | |
|
| |||
| TAPA1 | 0.45 (0.21)* | 0.44 (0.19) * | 0.32 (0.14) |
| TAPA2A | 0.18 (0.08)* | 0.17 (0.07) * | 0.13 (0.08) |
| TAPA2B | 0.13 (0.06)* | 0.13 (0.06)* | 0.11 (0.06) |
| TLOC | 0.54 (0.11)* | 0.56 (0.11) * | 0.50 (0.08) |
| TTOT | 1.34 (0.33)* | 1.35 (0.27)* | 1.09 (0.23) |
|
| |||
| VAPA1(x) | 0.05 (0.04)*+ | 0.08 (0.07)* | 0.15 (0.12) |
| VAPA2A(x) | 0.07 (0.07)*+ | 0.10 (0.08)* | 0.14 (0.10) |
| VAPA2B(x) | 0.09 (0.08)* | 0.12 (0.10)* | 0.18 (0.11) |
| VLOC(x) | 0.22 (0.06)*+ | 0.24 (0.10)* | 0.29 (0.10) |
| VAPA1(z) | 0.05 (0.05)*+ | 0.09 (0.07) | 0.08 (0.08) |
| VAPA2A(z) | 0.29 (0.18)*+ | 0.39 (0.26) | 0.39 (0.24) |
| VAPA2B(z) | 0.35 (0.23) | 0.42 (0.20) | 0.39 (0.23) |
| VLOC(z) | 0.03 (0.05) | 0.03 (0.03) | 0.02 (0.03) |
|
| |||
| LAPA1 | 0.029 (0.010)*+ | 0.041 (0.019) | 0.040 (0.019) |
| LAPA2A | 0.037 (0.018)+ | 0.052 (0.029) * | 0.035 (0.019) |
| LAPA2B | 0.036 (0.018) | 0.032 (0.026) | 0.028 0.025) |
| LLOC | 0.080 (0.011)*+ | 0.093 (0.023) | 0.092 (0.016) |
| LTOT | 0.180 (0.035)*+ | 0.216 (0.052)* | 0.192 (0.039) |
PWS (Prader-Willi Syndrome group), OG (Obese Group) and HG (Healthy Group). * = p < 0.05, PWS and/or OG Vs. HG;, + = p < 0.05, PWS Vs. OG
Values of median and quartile range for the calculated parameters during Gait Termination
| GAIT TERMINATION | |||
|---|---|---|---|
| PWS | OG | HG | |
|
| |||
| TSPA1 | 0.40 (0.08) | 0.46 (0.13) | 0.43 (0.11) |
| TSPA2A | 0.19 (0.16)* | 0.19 (0.15)* | 0.14 (0.09) |
| TSPA2B | 0.17 (0.10) | 0.13 (0.11) | 0.15 (0.13) |
| TSPA3 | 0.55 (0.12)*+ | 0.50 (0.22)* | 0.39 (0.05) |
| TTOT | 1.37 (0.25)* | 1.29 (0.40)* | 1.12 (0.23) |
|
| |||
| VSPA 1(x) | 0.26 (0.15)* | 0.29 (0.12)* | 0.37 (0.12) |
| VSPA2A(x) | 0.06 (0.07) | 0.07 (0.07) | 0.07 (0.09) |
| VSPA2B(x) | 0.08 (0.07) | 0.06 (0.09) | 0.10 (0.07) |
| VSPA3(x) | 0.03 (0.04) | 0.03 (0.04) | 0.03 (0.03) |
| VSPA1 (z) | 0.05 (0.09) | 0.06 (0.09) | 0.05 (0.09) |
| VSPA2A(z) | 0.19 (0.15)*+ | 0.27 (0.23) | 0.25 (0.25) |
| VSPA2B(z) | 0.33 (0.21) | 0.33 (0.38) | 0.27 (0.21) |
| VSPA3(z) | 0.02 (0.03)*+ | 0.04 (0.05) | 0.04 (0.06) |
|
| |||
| LSPA1 | 0.083 (0.038) | 0.088 (0.033) | 0.095 (0.033) |
| LSPA2A | 0.031 (0.018)* | 0.029 (0.031)* | 0.025 (0.023) |
| LSPA2B | 0.034 (0.013) | 0.032 (0.029) | 0.030 (0.017) |
| LSPA3 | 0.025 (0.019) | 0.028 (0.019)* | 0.022 (0.014) |
| LTOT | 0.175 (0.068) | 0.180 (0.053) | 0.175 (0.034) |
PWS (Prader-Willi Syndrome group), OG (Obese Group) and HG (Healthy Group). * = p < 0.05, PWS and/or OG Vs. HG;, + = p < 0.05, PWS Vs. OG
Fig. 3A representative comparison between the postural sway path of an individual representative of PWS group, one of the OG and one of the HG during GI task (a) and during the GT task (b)